- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02388503
The Effect of a Natural Extract on the Post-prandial Blood Glucose Response After Bread Consumption: a Dose-response of Efficacy
April 30, 2015 updated by: Unilever R&D
This study is designed to identify the minimal effective tested dose of fruit extract consumed with a bread which provides a reduction in venous post-prandial blood glucose compared to a reference bread.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Charitéplatz 1
-
Berlin, Charitéplatz 1, Germany, 10117
- Charité Research Organisation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria:
- Body mass index (BMI) ≥ 18.0 and ≤ 30.0 kg/m2.
- Apparently healthy males and females: no medical conditions which might affect the study measurements including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases.
- Fasting blood glucose value of subjects ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening.
Exclusion criteria:
- Use of antibiotics within 3 months before day 1; use of any other medication except paracetamol, within 14 days before day 1.
- Blood donation in the past 3 months and/or during the study.
- Reported intense sporting activities > 10 h/week.
- Consumption of > 14 units (female subjects) and > 21 units (male subjects) alcoholic drinks in a typical week.
- Reported dietary habits: medically prescribed diet, slimming diet, not used to eat 3 meals a day, vegetarian.
- If female, is pregnant (or has been pregnant during the last < 3 months) or will be planning pregnancy during the study period.
- If female, is lactating or has been lactating in the 6 weeks before screening and/or during the study period.
- Dislike, known allergy or intolerance to test products or other food products provided during the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Reference
No added fruit extract
|
|
|
Active Comparator: Active 1
lowest dose of fruit extract
|
|
|
Active Comparator: Active 2
low dose of fruit extract
|
|
|
Active Comparator: Active 3
medium dose of fruit extract
|
|
|
Active Comparator: Active 4
high dose of fruit extract
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Positive incremental post-prandial blood glucose area under the curve
Time Frame: 120 minutes
|
120 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Positive incremental post-prandial blood glucose area under the curve
Time Frame: 180 minutes
|
180 minutes
|
|
Post-prandial insulin response
Time Frame: 120 minutes
|
120 minutes
|
|
Post-prandial insulin response
Time Frame: 180 minutes
|
180 minutes
|
|
AUC of fruit extract calculated by a non-compartmental model
Time Frame: 180 minutes
|
180 minutes
|
|
AUC of fruit extract calculated by a population model
Time Frame: 180 minutes
|
180 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2015
Primary Completion (Actual)
March 1, 2015
Study Completion (Actual)
March 1, 2015
Study Registration Dates
First Submitted
February 10, 2015
First Submitted That Met QC Criteria
March 13, 2015
First Posted (Estimate)
March 17, 2015
Study Record Updates
Last Update Posted (Estimate)
May 1, 2015
Last Update Submitted That Met QC Criteria
April 30, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FDS-NAA-1946
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.